C12ORF4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.240800E-01
Normal-vs-Stage2
1.698160E-01
Normal-vs-Stage3
1.002980E-01
Normal-vs-Stage4
4.321000E-01
Stage1-vs-Stage2
9.419200E-01
Stage1-vs-Stage3
3.203800E-01
Stage1-vs-Stage4
5.963400E-01
Stage2-vs-Stage3
2.529600E-01
Stage2-vs-Stage4
5.326400E-01
Stage3-vs-Stage4
1.931220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.799980E-01
Normal-vs-AfricanAmerican
1.701770E-01
Normal-vs-Asian
4.902300E-02
Caucasian-vs-AfricanAmerican
9.749600E-01
Caucasian-vs-Asian
6.990500E-02
AfricanAmerican-vs-Asian
2.418200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.266000E-01
Normal-vs-Female
8.641800E-02
Male-vs-Female
9.724600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.130000E-01
Normal-vs-Age(41-60Yrs)
1.776950E-01
Normal-vs-Age(61-80Yrs)
1.724400E-01
Normal-vs-Age(81-100Yrs)
9.936500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.771800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.593600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.834600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.050390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.275400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.843400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.870410E-01
Normal-vs-Daily Drinker
8.796400E-03
Normal-vs-Weekly Drinker
1.513620E-01
Normal-vs-Occasional Drinker
1.294750E-01
Normal-vs-Social Drinker
3.232800E-01
Non Drinker-vs-Daily Drinker
3.800800E-01
Non Drinker-vs-Weekly Drinker
7.319000E-01
Non Drinker-vs-Occasional Drinker
3.833000E-01
Non Drinker-vs-Social Drinker
2.472400E-01
Daily Drinker-vs-Weekly Drinker
1.765160E-01
Daily Drinker-vs-Occasional Drinker
3.531700E-02
Daily Drinker-vs-Social Drinker
1.544050E-02
Weekly Drinker-vs-Occasional Drinker
6.705800E-01
Weekly Drinker-vs-Social Drinker
3.884000E-01
Occasional Drinker-vs-Social Drinker
5.574000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.201200E-01
Normal-vs-Grade 2
4.010200E-01
Normal-vs-Grade 3
7.328600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.550000E-01
Grade 1-vs-Grade 3
7.231800E-01
Grade 1-vs-Grade 4
4.201200E-01
Grade 2-vs-Grade 3
7.174800E-01
Grade 2-vs-Grade 4
4.010200E-01
Grade 3-vs-Grade 4
7.328600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.540370E-01
Normal-vs-NonDiabetic
1.062360E-01
Diabetic-vs-NonDiabetic
8.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.451800E-02
Normal-vs-NoPancreatitis
1.294200E-01
Pancreatitis-vs-NoPancreatitis
6.428600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.633200E-01
Normal-vs-N1
1.282600E-01
N0-vs-N1
5.591400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.288000E-01
Normal-vs-TP53-NonMutant
3.614800E-01
TP53-Mutant-vs-TP53-NonMutant
3.849600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
